kinases, p38 and ERK MAP kinases mediate TNF-α-induced CD38 expression through 54 modulating the transcript stability (27). We recently reported that, in ASM cells obtained 55 from subjects with history of asthma, TNF-α-induced CD38 expression was differentially 56 elevated, although the mechanistic basis of this differential elevation was not clearly 57 understood (15) . 58
MicroRNAs (miRNA) are non-coding small RNAs emerging as post-59 transcriptional regulators in various biological processes including inflammation. 60 inflammation and allergic airway hyperresponsiveness. The roles of let-7 and miR-155 in 69 IL-13 signaling, and the potential role of miR-133 on Rho-A expression were some of the 70 notable studies that highlight the roles of miRNA in the pathogenesis of airway 71 inflammatory disorders (5, (19) (20) (21) . In the present study, bioinformatic tools were used to 72 determine potential miRNA response elements in the 3'UTR of human CD38 gene. 73
Expression of miR-140-3p, which came as a top hit in one of the target prediction 74 algorithms, and its functional role in CD38 expression were determined in asthmatic and 75
were from de-identified healthy donors (non-asthmatic ASM cells-NAASM) and donors 104 who have died due to severe asthma (asthmatic ASM cells-AASM). All experiments 105
were conducted in HASM cells in their 4 th or 5 th passage. In all the experiments, prior to 106 exposure to TNF-α, the cells were growth-arrested for 48 h in arresting medium without 107 serum, but in the presence of transferrin and insulin. In experiments to determine the 108 expression of CD38 and miR-140-3p, cells were exposed to vehicle (0.1% bovine serum 109 albumin in PBS) or 10 ng/ml human recombinant TNF-α (rhTNF-α) for 0-24 hrs. To 110 determine CD38 mRNA stability, cells were exposed to TNF-α for 12 hrs, and then 111 washed to remove TNF-α before the addition of actinomycin D (5 μg/ml) to arrest 112 transcription. Total RNA was collected at 0, 6, 12 and 24 hrs after transcriptional arrest. 113
Data is reported for only 0 and 24 hr time points for brevity. In experiments to determine 114 the activation of NF-κB or MAP Kinases, cells were exposed to rhTNF-α (10 ng/ml) for 115 1 hr or 15 min, respectively. 116
Extraction of total RNA and cDNA synthesis 117
Total RNA was extracted from HASM cells following manufacturer's instructions 118 (miRvana, Ambion). Briefly, HASM cells (50,000-200,000 cells) were collected in sterile 119 PBS, centrifuged and the pellet was homogenized in a buffer provided in the kit. Column-120 eluted total RNA was quantified in Agilent Nano-drop bioanalyzer. To synthesize cDNA 121 from small RNA, 200 ng of total RNA was poly-adenylated and cDNA was synthesized 122 using NCode First strand synthesis kit according to manufacturer's instructions. In 123 parallel, 200 ng of total RNA was used to synthesize cDNA from larger RNA using 124
Superscript II reverse transcription kit.
Whole cell lysates were obtained by sonicating HASM cells (200,000-500,000 cells) in 127 lysis buffer (50 mM Tris, 100 mM NaCl, 50 mM NaF, 40 mM beta-glycerol phosphate, 2 128 mM EDTA, 0.2 mM Na 3 VO 4 , 1% Triton X-100, and protease inhibitor cocktail, pH 7.4). 129
Nuclear extracts were collected from HASM cells (500,000-600,000 cells) using NE-PER 130 cytoplasmic/nuclear extraction kit, according to the manufacturer's protocols. 131
Transient transfection of HASM cells 132
HASM cells were plated into appropriate formats and cell number (200, 000 cells/well in 133 6-well plate or 500, 000 cells/plate in 100-mm culture plate) 24 hrs prior to transfection. 134
Transfection was performed using Lipofectamine RNAimax according to the 135 manufacturer's instructions. Briefly, control oligonucleotide (C.ele-miR-67) or miR-140-136 3p mimic oligonucleotides or miR-140-3p antagomirs were transfected in a range of 137 concentrations (5-100 nM). Control oligonucleotide was transfected at 50 or 100 nM 138 concentrations. 139
qRT-PCR 140
To determine the miR-140-3p expression, a forward primer specific to the miR-140-3p 141 and a universal primer targeting the poly-T of the cDNA were used according to the 142 manufacturer's instructions. Mammalian small nuclear RNA U6 was used for 143 normalization of miR-140-3p expression. To determine CD38 expression, qRT-PCR was 144 performed using Brilliant SYBR Green master mix as described in a previous publication 145 (27). Cyclophilin was amplified as the house-keeping control. 146
Site-directed mutagenesis was performed in luciferase-CD38 3'UTR reporter plasmids. 149 CD38-3'UTR (481 bases long; UGC genome browser) has a predicted miR-140-3p target 150 site at 8 bases after the stop codon in the CD38 mRNA. The first miR-140-3p target had a 151 7-base complementarity to the miR-140-3p. A second target site with a 6-base 152 complementarity to miR-140-3p was found 21 bases away from the first target site. First 153 target site (mutated 1) or both target sites (mutated 1+2) were mutated to determine the 154 selectivity of miR140-3p binding to these sites. QuikChange Lightning multi site-directed 155 mutagenesis kit was used to mutate four bases (taGaGGa) at first target site (CTGTGGT) 156 or three bases (aGaGGa) at the second target site (TGTGGT) (Figure 2A , Upper panel). 157
Twenty bases flanking the target site with mutation was designed as primers for mutation. 158
The primers for each mutagenesis were as follows: First target site mutation primer: 159 The quantity of NAD generated in the reaction was calculated from a standard curve 192 generated from known NAD.
Data analysis 194
Each experiment was performed 3-6 times (NAASM or AASM cells obtained from 3-6 195 donors were used). The data from mRNA fold change, enzymatic activity and 196 densitometry ratio were expressed as mean±SEM and statistically analyzed by student t-197 test or one-way ANOVA (depending on the number of experimental groups analyzed) 198 using GraphPad Prism software. The differences were considered significant when the p 199 value was ≤ 0.05. showed that IL-13, a Th2 cytokine with prominent role in allergic asthma, downregulates 303 the expression of miR-133a (5). It is suggested that the downregulation of miR-133a 304 leads to elevated RhoA, a pro-contractile protein in the ASM cells. CD38 contributes to 305 the development of AHR in mouse models of asthma (10, 11). CD38 null mouse 306 developed significantly lower levels of airway responsiveness compared to the wild typedeveloped reduced AHR compared to that of wild type mouse, following brief exposure 309 to TNF-α or IL-13 (10, 11). Therefore, investigating the miRNAs that target CD38 gene 310 expression in HASM cells may lead to an understanding of the signaling pathways 311 involved in the pathogenesis of AHR and asthma. 312
Multiple web-based target prediction algorithms (Target Scan-313 www.targetscan.org, miRWalk-www.ma.uni-heidelberg.de and miRbase-314 www.mirbase.org) were used to determine potential miRNA targets in the CD38 3'UTR. 315
From the list of predicted miRNAs, miR-140-3p was chosen for further investigation 316 because it has been reported as one of the highly expressed miRNAs in HASM cells (32). 317
Furthermore, in HASM cells exposed to a mixture of inflammatory cytokines including 318 TNF-α, there is significant downregulation of several miRNAs, including miR-140 and 319 some miRNAs involved in the regulation of smooth muscle phenotype (17). In earlier 320 publications by other investigators, miR-140 has been reported as a cartilage-specific 321 miRNA in mouse and Zebrafish (29, 31). However, these reports were largely referring to 322 miR-140-5p, one of the two mature miRNAs originating from the precursor miR-140. In 323 the present study, we focused on miR-140-3p and its role in regulation of CD38 324 expression. 
